Literature DB >> 12459014

Antitumor imidazotetrazines. 41. Conjugation of the antitumor agents mitozolomide and temozolomide to peptides and lexitropsins bearing DNA major and minor groove-binding structural motifs.

Jill Arrowsmith1, Sharon A Jennings, Alan S Clark, Malcolm F G Stevens.   

Abstract

Carboxylic acids derived from the amido groups of the antitumor agents mitozolomide and temozolomide have been conjugated to simple amino acids and peptides by carbodiimide coupling. Solid-state peptide synthesis has been applied to link the acids to DNA major groove-binding peptidic motifs known to adopt alpha-helical conformations. Attachment of the acids to pyrrole and imidazole polyamidic lexitropsins gave a series of potential DNA minor groove-binding ligands. In vitro biological evaluation of a limited number of these novel conjugates failed to demonstrate any enhanced growth-inhibitory activity compared to the unconjugated drugs; sites of alkylation at tracts of multiple guanines were also unaffected. Attachment of additional residues at C-8 of the imidazotetrazines did not perturb the chemistry of activation of the bicyclic nucleus, and biological sequelae can be rationalized by invoking the liberation of a common, diffusible, reactive chemical intermediate, the methanediazonium ion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459014     DOI: 10.1021/jm020936d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Biological effects of novel "combi-targeting" molecule and its effect on DNA repair pathway in hormone-refractory prostate cancer.

Authors:  Youqiang Fang; Jieying Wu; Tengcheng Li; Yun Luo; Qiyu Qiu; Xinxin Quan; Li Gao; Wei Liu
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

2.  Modification of Microbial Polymalic Acid With Hydrophobic Amino Acids for Drug-Releasing Nanoparticles.

Authors:  Alberto Lanz-Landázuri; Montserrat García-Alvarez; José Portilla-Arias; Antxon Martínez de Ilarduya; Eggehard Holler; Julia Ljubimova; Sebastián Muñoz-Guerra
Journal:  Macromol Chem Phys       Date:  2012-08-14       Impact factor: 2.527

3.  Poly(methyl malate) nanoparticles: formation, degradation, and encapsulation of anticancer drugs.

Authors:  Alberto Lanz-Landázuri; Montserrat García-Alvarez; José Portilla-Arias; Antxon Martínez de Ilarduya; Rameshwar Patil; Eggehard Holler; Julia Y Ljubimova; Sebastián Muñoz-Guerra
Journal:  Macromol Biosci       Date:  2011-07-25       Impact factor: 4.979

4.  Investigating the Stability of Six Phenolic TMZ Ester Analogues, Incubated in the Presence of Porcine Liver Esterase and Monitored by HPLC.

Authors:  Leroy A Shervington; Oliver Ingham
Journal:  Molecules       Date:  2022-05-05       Impact factor: 4.927

5.  A cyclic-RGD-BioShuttle functionalized with TMZ by DARinv "Click Chemistry" targeted to αvβ3 integrin for therapy.

Authors:  Klaus Braun; Manfred Wiessler; Rüdiger Pipkorn; Volker Ehemann; Tobias Bäuerle; Heinz Fleischhacker; Gabriele Müller; Peter Lorenz; Waldemar Waldeck
Journal:  Int J Med Sci       Date:  2010-09-21       Impact factor: 3.738

6.  Temozolomide nanoparticles for targeted glioblastoma therapy.

Authors:  Chen Fang; Kui Wang; Zachary R Stephen; Qingxin Mu; Forrest M Kievit; Daniel T Chiu; Oliver W Press; Miqin Zhang
Journal:  ACS Appl Mater Interfaces       Date:  2015-03-18       Impact factor: 9.229

7.  Vinylogous reactivity of enol diazoacetates with donor-acceptor substituted hydrazones. Synthesis of substituted pyrazole derivatives.

Authors:  Xinfang Xu; Peter Y Zavalij; Wenhao Hu; Michael P Doyle
Journal:  J Org Chem       Date:  2013-01-24       Impact factor: 4.354

8.  A platform for specific delivery of lanthanide-scandium mixed-metal cluster fullerenes into target cells.

Authors:  Anna Svitova; Klaus Braun; Alexey A Popov; Lothar Dunsch
Journal:  ChemistryOpen       Date:  2012-09-28       Impact factor: 2.911

9.  The medicinal chemistry of imidazotetrazine prodrugs.

Authors:  Catherine L Moody; Richard T Wheelhouse
Journal:  Pharmaceuticals (Basel)       Date:  2014-07-10

10.  Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma.

Authors:  Sarah M Ward; Matthew Skinner; Banishree Saha; Todd Emrick
Journal:  Mol Pharm       Date:  2018-10-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.